Minimize Uncertainty – Make Informed Decisions – Succeed

Rare Disease news

Rare Diseases Today—March 12, 2026

March 12, 2026Therna Biosciences,Charles River,Fabry Disease,Lamb-Shaffer Syndrome,BioPharma and Tech News,Sangamo Therapeutics,Alexion,ST-920,AstraZeneca Rare Disease,Ultra-Rare Lung Fibrosis,KOSELUGO,Protalix BioTherapeutics,Neurofibromatosis Type 1,Andelyn Biosciences,Lundbeck,Palvella Therapeutics,GeneDx,Eledon Pharmaceuticals,Rare Disease News,Tegoprubart,Elfabrio,Liver Transplantation,Zevra Therapeutics,Amlenetug,Niemann–Pick disease type C,Multiple System Atrophymicrocystic lymphatic malformations,Chiesi Global Rare Diseases

This week’s Rare Diseases update highlights regulatory approvals, gene therapy…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million

March 12, 2026Oncology,market access,diagnostics,Lucid Diligence Brief,diligence,companion diagnostics,pathology,Agilent,Biocare Medical,immunohistochemistry,clinical diagnosticshealthcare M&A

Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million…

by Timos Papagatsias

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap—March 11, 2026

March 11, 2026emergency triage,suicide-risk alerts,remote patient monitoring,Indo-French Centre for AI in Health,astrazeneca,CNS drug discovery,merck,genome foundation model,Insilico Medicine,AI-native clinical development,schizophrenia,BioPharma and Tech News,Bipolar Disorder,Mayo Clinic,OpenAI,AI in Healthcare and Digital Health,Major depressive disorder,ChatGPT HealthEvo 2,consumer triage AI

This biweekly AI in Healthcare and Digital Health video recap highlights safety…

by Timos Papagatsias

Neuroscience

Neuroscience Today—March 11, 2026

March 11, 2026Focal Onset Seizures,Bipolar Mania,Alzheimer's Disease,Therna Biosciences,Duchenne Muscular Dystrophy,Charles River,BioPharma and Tech News,Lamb-Shaffer Syndrome,TG Therapeutics,Z-Rostudirsen,BRIUMVI,Z-Basivarsen,Dyne Therapeutics,SPR,Neuroscience News,SPRINT Peripheral Nerve Stimulation,Relapsing multiple sclerosis,Chronic Shoulder Pain,myotonic dystrophy type 1,cognito therapeutics,spectris,Rapport TherapeuticsTenacia Biotechnology,RAP-219

This week’s Neuroscience update highlights partnership activity, clinical trial…

by LucidQuest

Immunology

Immunology Video Recap—March 11, 2026

March 11, 2026Immunology News,IMAAVYDupixent,abbvie,Systemic lupus erythematosus,pfizer,Allergic fungal rhinosinusitis,roche,risankizumab,sanofi,SKYRIZI,Atopic Dermatitis,Nipocalimab,BioPharma and Tech News,warm autoimmune hemolytic anemia,psoriatic arthritis,obinutuzumab,Crohns Disease,Gazyva,Dupilumab,Tilrekimig,Regeneron,NUMELVI,Johnson & Johnson,Atinvicitinib,Deucravacitinib,Merck Animal Health,Sotyktu,Allergic Dermatitis,Bristol Myers Squibb,Canine Pruritus

This biweekly Immunology video recap highlights regulatory approvals,…

by LucidQuest

Immunology

Immunology Today—March 11, 2026

March 11, 2026Deucravacitinib,Nemluvio,Sotyktu,Nemolizumab,Amgen,Bristol Myers Squibb,gsk,Immunology News,pfizer,Systemic lupus erythematosus,roche,primary biliary cholangitis,sanofi,Teva Pharmaceuticals,Atopic Dermatitis,Prurigo nodularis,BioPharma and Tech News,Nipocalimab,psoriatic arthritis,obinutuzumab,Galderma,Duvakitug,Ulcerative Colitis,Gazyva,Crohns Disease,Gazyvaro,Johnson & Johnson,Tilrekimig,Rocatinlimab,AlfasigmaKyowa Kirin,Linerixibat

This week’s Immunology update highlights regulatory progress, positive…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge

March 11, 2026clinical trials,market access,reimbursement,Regulatory,Eli Lilly,biopharma,Lucid Diligence Brief,diligence,South Korea,Gateway Labs,biotech incubatorSamsung Biologics

Lucid Diligence Brief: Eli Lilly $500 million South Korea biopharma pledge…

by Timos Papagatsias

Endocrinology

Endocrinology Today—March 10, 2026

March 10, 2026Zandoriah,EB613,semaglutide,Postmenopausal Osteoporosis,BioPharma and Tech News,BONE-Net,Eli Lilly,Helmholtz Munich,osteoporosis,Akkermansia muciniphila PROBIO,type 2 diabetes,Insulin Efsitora Alfa,type 1 diabetes,Zydus,Sun Pharma,Natco,Dr. Reddy’s,Endocrinology News,Entera Bio,Polycystic ovary syndrome,LupinFunctional hypothalamic amenorrhea,CinnaGen

This week’s Endocrinology update highlights regulatory progress in osteoporosis…

by LucidQuest

Obesity Weekly News

Obesity Today—March 10, 2026

March 10, 2026Glucagon-Like Peptide-1 Receptor Agonists,wegovy,semaglutide,pfizer,BioPharma and Tech News,obesity,Novo Nordisk,Tirzepatide,Zepbound,Eli Lilly,Ozempic,Obesity News,Sciwind BiosciencesEcnoglutide,Aspen Pharmacare

This week’s Obesity update highlights regulatory approvals, emerging generic…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: kyron.bio x Servier strategic partnership

March 10, 2026biotech,Oncology,drug development,Autoimmune Disease,Servier,CMC,Lucid Diligence Brief,antibody therapeutics,platform diligence,glycoengineering,glycosylation,kyron.biobiologics manufacturing

Lucid Diligence Brief: kyron.bio x Servier strategic partnership Professional…

by Timos Papagatsias

Hematology

Hematology Video Recap—March 9, 2026

March 9, 2026Hematology News,Oryzon Genomicsalpha-thalassemia,takeda,mitapivat,Tecvayli,essential thrombocythemia,Sickle Cell Disease,Protagonist Therapeutics,BioPharma and Tech News,Rusfertide,Daratumumab,Agios,PYRUKYND,Fulcrum Therapeutics,Bleximenib,Pociredir,Reblozyl,luspatercept,Polycythemia Vera,relapsed refractory multiple myeloma,Johnson & Johnson,Blackstone Life Sciences,teclistamab,iadademstat,Darzalex Faspro,Sutacimig,Bristol Myers Squibb,Hemab Therapeutics,Acute Myeloid Leukemia,Glanzmann Thrombasthenia

This biweekly Hematology video recap highlights regulatory approvals, priority…

by LucidQuest

Hematology

Hematology Today—March 9, 2026

March 9, 2026Rusfertide,Agios,takeda,AN2 Therapeutics,Tecvayli,Epetraborole,BioPharma and Tech News,Starton Therapeutics,PYRUKYND,relapsed refractory multiple myeloma,Polycythemia Vera,LYMPHIR,Thalassemia,Citius Oncology,Darzalex Faspro,Cytarabine,Acute Myeloid Leukemia,Mitoxantrone,Hematology News,Certara,venetoclax,Asciminib,Diffuse large B-cell lymphoma,Sutacimig,Chronic myeloid leukemia,Hemab Therapeutics,Protagonist TherapeuticsGlanzmann Thrombasthenia,Lenalidomide

This week’s Hematology update highlights regulatory approvals, priority review…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.